VanEck Associates’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.92M | Buy |
33,353
+2,861
| +9% | +$595K | ﹤0.01% | 694 |
|
|
2026
Q1 | $6.44M | Sell |
30,492
-1,541
| -5% | -$332K | ﹤0.01% | 733 |
|
|
2025
Q4 | $6.58M | Sell |
32,033
-1,726
| -5% | -$325K | 0.01% | 698 |
|
|
2025
Q3 | $5.3M | Buy |
33,759
+458
| +1% | +$70.7K | ﹤0.01% | 747 |
|
|
2025
Q2 | $5.59M | Buy |
33,301
+3,313
| +11% | +$492K | 0.01% | 683 |
|
|
2025
Q1 | $4.13M | Sell |
29,988
-1,080
| -3% | -$138K | 0.01% | 781 |
|
|
2024
Q4 | $3.67M | Sell |
31,068
-928
| -3% | -$108K | ﹤0.01% | 801 |
|
|
2024
Q3 | $3.58M | Buy |
31,996
+1,507
| +5% | +$158K | ﹤0.01% | 762 |
|
|
2024
Q2 | $3M | Buy |
30,489
+2,833
| +10% | +$289K | ﹤0.01% | 760 |
|
|
2024
Q1 | $3.1M | Buy |
27,656
+4,938
| +22% | +$533K | ﹤0.01% | 739 |
|
|
2023
Q4 | $2.29M | Sell |
22,718
-2,237
| -9% | -$222K | ﹤0.01% | 767 |
|
|
2023
Q3 | $2.17M | Buy |
24,955
+1,823
| +8% | +$165K | ﹤0.01% | 735 |
|
|
2023
Q2 | $2.19M | Buy |
23,132
+4,003
| +21% | +$338K | ﹤0.01% | 705 |
|
|
2023
Q1 | $1.44M | Sell |
19,129
-3,756
| -16% | -$283K | ﹤0.01% | 758 |
|
|
2022
Q4 | $1.76M | Sell |
22,885
-5,968
| -21% | -$453K | ﹤0.01% | 700 |
|
|
2022
Q3 | $1.92M | Buy |
28,853
+1,127
| +4% | +$71.4K | 0.01% | 656 |
|
|
2022
Q2 | $1.45M | Sell |
27,726
-7,487
| -21% | -$426K | ﹤0.01% | 720 |
|
|
2022
Q1 | $2M | Sell |
35,213
-8,122
| -19% | -$435K | ﹤0.01% | 703 |
|
|
2021
Q4 | $2.23M | Sell |
43,335
-5,752
| -12% | -$282K | 0.01% | 690 |
|
|
2021
Q3 | $2.43M | Sell |
49,087
-137
| -0.3% | -$7.43K | 0.01% | 624 |
|
|
2021
Q2 | $2.81M | Buy |
49,224
+9,221
| +23% | +$539K | 0.01% | 579 |
|
|
2021
Q1 | $2.43M | Sell |
40,003
-5,461
| -12% | -$301K | 0.01% | 564 |
|
|
2020
Q4 | $2.44M | Sell |
45,464
-17,489
| -28% | -$907K | 0.01% | 506 |
|
|
2020
Q3 | $2.96M | Buy |
62,953
+16,936
| +37% | +$869K | 0.01% | 414 |
|
|
2020
Q2 | $2.4M | Buy |
46,017
+21,357
| +87% | +$1.1M | 0.01% | 456 |
|
|
2020
Q1 | $1.18M | Sell |
24,660
-1,225
| -5% | -$63.6K | 0.01% | 537 |
|
|
2019
Q4 | $1.31M | Buy |
25,885
+5,161
| +25% | +$267K | 0.01% | 585 |
|
|
2019
Q3 | $978K | Sell |
20,724
-597,701
| -97% | -$27.3M | ﹤0.01% | 596 |
|
|
2019
Q2 | $29.1M | Sell |
618,425
-506,261
| -45% | -$23.4M | 0.14% | 147 |
|
|
2019
Q1 | $54.2M | Buy |
1,124,686
+258,471
| +30% | +$12.9M | 0.27% | 90 |
|
|
2018
Q4 | $38.6M | Buy |
866,215
+104,696
| +14% | +$5.46M | 0.19% | 106 |
|
|
2018
Q3 | $41.1M | Buy |
761,519
+143,073
| +23% | +$7.32M | 0.2% | 119 |
|
|
2018
Q2 | $30.2M | Buy |
618,446
+65,724
| +12% | +$3.73M | 0.14% | 145 |
|
|
2018
Q1 | $34.6M | Buy |
552,722
+16,153
| +3% | +$1.11M | 0.17% | 121 |
|
|
2017
Q4 | $32.9M | Buy |
536,569
+275,903
| +106% | +$17.1M | 0.16% | 138 |
|
|
2017
Q3 | $17.4M | Buy |
260,666
+234,172
| +884% | +$16.6M | 0.09% | 178 |
|
|
2017
Q2 | $2.06M | Sell |
26,494
-10,775
| -29% | -$813K | 0.01% | 397 |
|
|
2017
Q1 | $3.04M | Sell |
37,269
-9,188
| -20% | -$723K | 0.01% | 357 |
|
|
2016
Q4 | $3.34M | Sell |
46,457
-10,105
| -18% | -$731K | 0.02% | 342 |
|
|
2016
Q3 | $4.39M | Sell |
56,562
-5,113
| -8% | -$413K | 0.02% | 311 |
|
|
2016
Q2 | $4.81M | Buy |
61,675
+3,629
| +6% | +$289K | 0.02% | 270 |
|
|
2016
Q1 | $4.76M | Sell |
58,046
-9,902
| -15% | -$805K | 0.03% | 224 |
|
|
2015
Q4 | $6.07M | Sell |
67,948
-9,530
| -12% | -$809K | 0.05% | 218 |
|
|
2015
Q3 | $5.95M | Sell |
77,478
-4,058
| -5% | -$339K | 0.05% | 221 |
|
|
2015
Q2 | $6.82M | Sell |
81,536
-36,294
| -31% | -$3.2M | 0.04% | 237 |
|
|
2015
Q1 | $10.6M | Buy |
117,830
+48,202
| +69% | +$4.15M | 0.06% | 198 |
|
|
2014
Q4 | $5.62M | Buy |
69,628
+39,595
| +132% | +$3.13M | 0.03% | 244 |
|
|
2014
Q3 | $2.25M | Buy |
30,033
+11,048
| +58% | +$804K | 0.01% | 325 |
|
|
2014
Q2 | $1.3M | Buy |
18,985
+7,234
| +62% | +$492K | 0.01% | 390 |
|
|
2014
Q1 | $822K | Sell |
11,751
-11,885
| -50% | -$826K | ﹤0.01% | 401 |
|
|
2013
Q4 | $1.58M | Sell |
23,636
-2,169
| -8% | -$133K | 0.01% | 337 |
|
|
2013
Q3 | $1.35M | Buy |
25,805
+2,748
| +12% | +$140K | 0.01% | 337 |
|
|
2013
Q2 | $1.09M | Buy |
+23,057
| New | +$1.05M | 0.01% | 349 |
|
Other funds holding CAH
VanEck Associates's CAH Position: Q2 2026 in Review
VanEck Associates increased its Cardinal Health (CAH) stake by 9.4% in Q2 2026, buying an estimated $595K and bringing the position to 33,353 shares worth $7.92M. The position accounts for ﹤0.01% of the portfolio, ranked #694.
VanEck Associates first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $54.2M in Q1 2019. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- VanEck Associates held 33,353 shares of Cardinal Health worth $7.92M as of Q2 2026.
- VanEck Associates bought 2,861 Cardinal Health shares in Q2 2026, an estimated $595K.
- Cardinal Health made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #694 holding.
- VanEck Associates first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- VanEck Associates's Cardinal Health position peaked at $54.2M in Q1 2019.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.